23 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, including a principal of accountability and the obligation to demonstrate compliance through policies, procedures, training and audit. In addition, some … among different CROs and trial sites;
delays in identifying, recruiting and training suitable clinical investigators;
obtaining approval or positive
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
annually, or for employees will arrange for certification via the Company’s online training system (if applicable).
* * * * *
Effective Version
Description
F-1/A
dliuyd bm
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
iiyjmltoq18 xwduf
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
v5nlu80blk9wnn9uf0jx
16 Jul 19
Current report (foreign)
8:21am
20-F
xb5doun
29 Apr 19
Annual report (foreign)
4:59pm
424B3
3urpr5b kfara0aoy6wu
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
x2wa9p vk
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
EX-10.9
q6dpc
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.22
6j5qzv4v8h4ezoe
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.13
x5k6rbwb ml
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.20
bb14uci0ou3 iiludva
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
52j 8pbixfgfastnnu1
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.10
8e4efol4i36to1s0ag
25 Jan 19
Registration of securities (foreign)
12:00am